Bath Savings Trust Co Buys Shares of 2,382 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bath Savings Trust Co bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 1st quarter, according to its most recent disclosure with the SEC. The fund bought 2,382 shares of the company’s stock, valued at approximately $217,000.

Several other institutional investors also recently bought and sold shares of the company. Fiduciary Trust Co grew its position in GE HealthCare Technologies by 1.8% in the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock valued at $595,000 after acquiring an additional 133 shares in the last quarter. Janney Capital Management LLC grew its position in shares of GE HealthCare Technologies by 4.7% during the fourth quarter. Janney Capital Management LLC now owns 3,289 shares of the company’s stock worth $254,000 after buying an additional 149 shares in the last quarter. American National Bank grew its position in shares of GE HealthCare Technologies by 25.2% during the fourth quarter. American National Bank now owns 750 shares of the company’s stock worth $58,000 after buying an additional 151 shares in the last quarter. Chilton Capital Management LLC grew its position in shares of GE HealthCare Technologies by 15.4% during the fourth quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock worth $95,000 after buying an additional 164 shares in the last quarter. Finally, Prudential PLC grew its position in shares of GE HealthCare Technologies by 0.9% during the fourth quarter. Prudential PLC now owns 20,022 shares of the company’s stock worth $1,548,000 after buying an additional 174 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other GE HealthCare Technologies news, insider Frank R. Jimenez acquired 1,315 shares of the business’s stock in a transaction on Wednesday, May 1st. The stock was purchased at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the transaction, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other GE HealthCare Technologies news, insider Frank R. Jimenez acquired 1,315 shares of the business’s stock in a transaction on Wednesday, May 1st. The stock was purchased at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the transaction, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Jan Makela sold 20,227 shares of the firm’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the completion of the transaction, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The disclosure for this sale can be found here. Over the last quarter, insiders sold 90,482 shares of company stock worth $7,369,137. 0.27% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have recently commented on GEHC. Evercore ISI boosted their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. The Goldman Sachs Group began coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective for the company. Bank of America lowered their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Argus boosted their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Finally, Mizuho decreased their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $94.09.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $78.27 on Thursday. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. The stock has a fifty day moving average price of $80.85 and a 200 day moving average price of $81.33. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company has a market cap of $35.73 billion, a PE ratio of 22.89, a P/E/G ratio of 2.81 and a beta of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same period last year, the company earned $0.85 earnings per share. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date of this dividend was Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.